Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

3 results about "Uncoupling protein" patented technology

An uncoupling protein (UCP) is a mitochondrial inner membrane protein that is a regulated proton channel or transporter. An uncoupling protein is thus capable of dissipating the proton gradient generated by NADH-powered pumping of protons from the mitochondrial matrix to the mitochondrial intermembrane space. The energy lost in dissipating the proton gradient via UCPs is not used to do biochemical work. Instead, heat is generated. This is what links UCP to thermogenesis. UCPs are positioned in the same membrane as the ATP synthase, which is also a proton channel. The two proteins thus work in parallel with one generating heat and the other generating ATP from ADP and inorganic phosphate, the last step in oxidative phosphorylation. Mitochondria respiration is coupled to ATP synthesis (ADP phosphorylation) but is regulated by UCPs.

Application of hippuric acid in activating brown adipose tissue to produce heat and preventing and treating obesity

PendingCN121489926AOrganic active ingredientsMetabolism disorderGlycolipid metabolismMetabolite
The invention discloses application of hippuric acid in activation of brown adipose tissue heat production and prevention and treatment of obesity, and the application is realized by activating brown adipose tissue heat production, specifically, expression of uncoupling protein 1 in brown adipose tissue is up-regulated, heat production capacity under cold stimulation conditions is enhanced, weight gain and abnormal glucose and lipid metabolism are improved, and the purpose of preventing and treating obesity is achieved. The hippuric acid is preferably derived from walnut oil or metabolites thereof, and has a good application prospect.
Owner:JIANGNAN UNIV

Adipose cell, white fat browning cell model, construction method and application

The invention provides an adipocyte, a white adipose browning cell model and a construction method and application, and relates to the technical field of biological medicine, the adipocyte contains an exogenous nucleic acid construct for specifically inhibiting Kdm7a gene expression; expression of the endogenous Kdm7a gene in fat cells is inhibited and an uncoupling protein 1 is expressed. By specifically inhibiting the expression of Kdm7a, the adipocyte can obviously express the uncoupling protein 1 and presents a stable brown adipotype, so that the defects of limited cell source, complex induction and high heterogeneity in the prior art are effectively overcome; a standardized model which is simple and convenient to operate, wide in source and definite in function is provided for metabolic disease mechanism research and drug screening.
Owner:CHONGQING MEDICAL UNIVERSITY

Drug combination for treating obesity

The present invention provides methods of treating obesity, pre-diabetes, diabetes, and / or obese breast cancer, by increasing mitochondrial metabolism by increasing the activity of uncoupling protein 1 (UCP1) in adipocytes. The disclosed methods comprise contacting an adrenergic receptor agonist with an adipocyte in which the genomic activity of estrogen receptor beta (ERβ) has been inhibited or inactivated. In certain aspects, inhibition or inactivation of the genomic activity of ERβ is achieved by contacting the adipocyte with an ERβ ligand that selectively inhibits or inactivates the ERβ genomic activity.
Owner:THE CURATORS OF THE UNIVERSITY OF MISSOURI